Funding just became easier for doctoral students in the chemistry department, thanks to professor emeritus Edward C. “Ted” Taylor. With royalties from a top-selling cancer drug, Alimta, he invented for Eli Lilly & Co., Taylor has endowed fellowships for third-year chemistry Ph.D. students — usually about 30 students per year.
“That’s when they ought to be completely free of other concerns so they can devote themselves totally to their research,” says the 92-year-old Taylor. His work already has made a crucial difference to scientists at Princeton: The University’s Alimta royalties paid for the department’s quarter-billion-dollar new home, Frick Chemistry Laboratory, which opened in 2010.
The Latest
See all
Related News
A Father’s Death Leads to a Healing Mother-Son Road Trip Across Croatia
Silence speaks loudly for Darren Joe ’02 during a three-week trip down the Croatian coast
Water Polo Scoring Leader Roko Pozaric ’25 Elevates Princeton’s Goals
Remembering Landon Y. Jones ’66, Editor, Author, and Inveterate ‘Ripper’
Friends paid tribute Nov. 15 at a memorial service in the Princeton University Chapel
1 Response
Christina Bodurow *84
8 Years AgoTed Taylor’s Gift
Re “A Toast to Ted” (feature, April 6): As a mentee of Ted Taylor during my graduate studies and an Eli Lilly and Co. employee for many years, I would like to reinforce how proud his students, mentees, and Lilly colleagues are of this amazing legacy Ted has established for Princeton chemistry. Thank you, Ted!